These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes. Kundu SK; Merigan TC AIDS; 1992 Jul; 6(7):643-9. PubMed ID: 1354446 [TBL] [Abstract][Full Text] [Related]
3. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years. de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984 [TBL] [Abstract][Full Text] [Related]
4. Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children. Paul ME; Shearer WT; Kozinetz CA; Lewis DE J Allergy Clin Immunol; 2001 Aug; 108(2):258-64. PubMed ID: 11496243 [TBL] [Abstract][Full Text] [Related]
5. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement. Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143 [TBL] [Abstract][Full Text] [Related]
6. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies. van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847 [TBL] [Abstract][Full Text] [Related]
7. Multiple CTL specificities against autologous HIV-1-infected BLCLs. Ahearne PM; Morgan RA; Sebastian MW; Bolognesi DP; Weinhold KJ Cell Immunol; 1995 Mar; 161(1):34-41. PubMed ID: 7867083 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T lymphocyte activity in children infected with HIV. Froebel KS; Aldhous MC; Mok JY; Hayley J; Arnott M; Peutherer JF AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S83-8. PubMed ID: 7865339 [TBL] [Abstract][Full Text] [Related]
9. CD8+CD38+ and CD8+DR+ peripheral blood lymphoid subsets of HIV-infected intravenous drug abusers correlate with CD4+ cell counts and proliferation to mitogens. Echaniz P; Arrizabalaga J; Iribarren JA; Cuadrado E Cell Immunol; 1993 Aug; 150(1):72-80. PubMed ID: 7688270 [TBL] [Abstract][Full Text] [Related]
10. Rat cytotoxic T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens. Noguchi Y; Tateno M; Kondo N; Yoshiki T; Shida H; Nakayama E; Shiku H J Immunol; 1989 Dec; 143(11):3737-42. PubMed ID: 2479689 [TBL] [Abstract][Full Text] [Related]
11. Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up. Liu Z; Hultin LE; Cumberland WG; Hultin P; Schmid I; Matud JL; Detels R; Giorgi JV Cytometry; 1996 Mar; 26(1):1-7. PubMed ID: 8809474 [TBL] [Abstract][Full Text] [Related]
12. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice. Chenciner N; Michel F; Dadaglio G; Langlade-Demoyen P; Hoffenbach A; Leroux A; Garcia-Pons F; Rautmann G; Guy B; Guillon JM Eur J Immunol; 1989 Sep; 19(9):1537-44. PubMed ID: 2676560 [TBL] [Abstract][Full Text] [Related]
13. Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses. Negri DR; Buffa V; Leone P; Bona R; Borghi M; Carlini F; De Angelis F; Indraccolo S; Ensoli B; Cara A J Immunol Methods; 2004 Aug; 291(1-2):153-63. PubMed ID: 15345313 [TBL] [Abstract][Full Text] [Related]
14. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection. Kestens L; Vanham G; Gigase P; Young G; Hannet I; Vanlangendonck F; Hulstaert F; Bach BA AIDS; 1992 Aug; 6(8):793-7. PubMed ID: 1418775 [TBL] [Abstract][Full Text] [Related]
15. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442 [TBL] [Abstract][Full Text] [Related]
16. Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals. Restrepo C; Rallón NI; del Romero J; Rodríguez C; Hernando V; López M; Peris A; Lozano S; Sempere-Ortells JM; Soriano V; Benito JM J Immunol; 2010 Jul; 185(2):982-9. PubMed ID: 20543099 [TBL] [Abstract][Full Text] [Related]
17. Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers. Scott-Algara D; Buseyne F; Blanche S; Rouzioux C; Jouanne C; Romagné F; Rivière Y J Infect Dis; 2001 Jun; 183(11):1565-73. PubMed ID: 11343205 [TBL] [Abstract][Full Text] [Related]
18. Loss of T-cell cytotoxic responses in the course of HIV-1 infection. Zerhouni B; Sanhadji K; Touraine JL Thymus; 1997; 24(4):203-19. PubMed ID: 9493284 [TBL] [Abstract][Full Text] [Related]
20. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones. van Binnendijk RS; Poelen MC; de Vries P; Voorma HO; Osterhaus AD; Uytdehaag FG J Immunol; 1989 Apr; 142(8):2847-54. PubMed ID: 2467943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]